U.S. approves Barr generic version of Roche's Vesanoid
June 22 (Reuters) - Barr Pharmaceuticals Inc. BRL.N said U.S. regulators approved its generic version of Roche Laboratories Inc.'s Vesanoid capsules, used to treat a form of leukemia.
Barr said it plans to launch 10 mg capsules of tretinoin immediately. Vesanoid had sales of $24 million in the year to April, the company said.
Roche Laboratories is a subsidiary of Swiss drug maker Roche Holdings AG (ROG.VX)
(Reporting by Debojyoti Ghosh in Bangalore)
((Reuters Messaging:debojyoti.ghosh.reuters.com@reuters.net; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: BARR APPROVAL/
(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS4560
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters